Seven Eight Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,827
Closed -$5.16M 349
2024
Q3
$5.16M Buy
5,827
+3,709
+175% +$3.33M 0.46% 27
2024
Q2
$1.92M Buy
2,118
+1,258
+146% +$1.01M 0.2% 149
2024
Q1
$669K Sell
860
-10,957
-93% -$7.8M 0.07% 402
2023
Q4
$6.89M Buy
+11,817
New +$6.9M 0.8% 13
2022
Q4
Sell
-4,643
Closed -$1.5M 538
2022
Q3
$1.5M Sell
4,643
-2,411
-34% -$764K 0.3% 96
2022
Q2
$2.29M Buy
+7,054
New +$2.12M 0.92% 10
2022
Q1
Sell
-3,813
Closed -$1.05M 628
2021
Q4
$1.05M Buy
+3,813
New +$967K 0.19% 162
2021
Q3
Sell
-1,789
Closed -$411K 658
2021
Q2
$411K Buy
+1,789
New +$359K 0.06% 452
2018
Q3
Sell
-3,720
Closed -$317K 642
2018
Q2
$317K Buy
+3,720
New +$306K 0.02% 403
2018
Q1
Sell
-19,291
Closed -$1.63M 461
2017
Q4
$1.63M Buy
+19,291
New +$1.64M 0.17% 212
2017
Q3
Sell
-891
Closed -$73K 534
2017
Q2
$73K Buy
+891
New +$72.7K 0.01% 461
2017
Q1
Sell
-52,891
Closed -$3.89M 611
2016
Q4
$3.89M Buy
+52,891
New +$3.94M 0.78% 12
2016
Q1
Sell
-4,291
Closed -$362K 624
2015
Q4
$362K Buy
+4,291
New +$356K 0.25% 146
2015
Q2
Sell
-3,991
Closed -$290K 599
2015
Q1
$290K Buy
+3,991
New +$284K 0.48% 63
2014
Q3
Sell
-10,500
Closed -$653K 608
2014
Q2
$653K Buy
+10,500
New +$626K 0.63% 33

Other funds holding LLY

Seven Eight Capital's LLY Position: Q4 2024 in Review

Seven Eight Capital sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 5,827 shares — an estimated $5.16M sold.

Seven Eight Capital first reported a position in LLY in Q2 2014 and held it in 15 quarters. The position peaked at $6.89M in Q4 2023. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Seven Eight Capital reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 5,827 Eli Lilly shares in Q4 2024, an estimated $5.16M.
  • Seven Eight Capital first reported a position in Eli Lilly in Q2 2014 and held it in 15 quarters.
  • Seven Eight Capital's Eli Lilly position peaked at $6.89M in Q4 2023.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.